Related references
Note: Only part of the references are listed.Expression of vFLIP in a Lentiviral Vaccine Vector Activates NF-κB, Matures Dendritic Cells, and Increases CD8+ T-Cell Responses
Helen M. Rowe et al.
JOURNAL OF VIROLOGY (2009)
HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells
Bingbing Dai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation
Spencer W. Stonier et al.
BLOOD (2008)
Expression of Costimulatory Ligand CD70 on Steady-State Dendritic Cells Breaks CD8+ T Cell Tolerance and Permits Effective Immunity
Anna M. Keller et al.
IMMUNITY (2008)
Dendritic cells in vivo: A key target for a new vaccine science
Ralph M. Steinman
IMMUNITY (2008)
Engineered lentivector targeting of dendritic cells for in vivo immunization
Lili Yang et al.
NATURE BIOTECHNOLOGY (2008)
Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8(+) and CD4(+) T-cell responses
Luciene Lopes et al.
JOURNAL OF VIROLOGY (2008)
Recombinant lentivector as a genetic immunization vehicle for antitumor immunity
Yukai He et al.
EXPERT REVIEW OF VACCINES (2007)
Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting
Paul J. Tacken et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Engineering targeted viral vectors for gene therapy
Reinhard Waehler et al.
NATURE REVIEWS GENETICS (2007)
Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics
K. Breckpot et al.
GENE THERAPY (2007)
Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines
Richard C. Koya et al.
MOLECULAR THERAPY (2007)
An essential role for Akt1 in dendritic cell function and tumor immunotherapy
Dongsu Park et al.
NATURE BIOTECHNOLOGY (2006)
Skin-derived dendritic cells induce potent CD8+ T cell immunity in recombinant lentivector-mediated genetic immunization
Yukai He et al.
IMMUNITY (2006)
Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN
I Caminschi et al.
INTERNATIONAL IMMUNOLOGY (2006)
Comparison of recombinant adenovirus and synthetic peptide for DC- based melanoma vaccination
J Steitz et al.
CANCER GENE THERAPY (2006)
Melanosomal targeting sequences from gp100 are essential for MHC class II-restricted endogenous epitope presentation and mobilization to endosomal compartments
S Lepage et al.
CANCER RESEARCH (2006)
Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene
HM Rowe et al.
MOLECULAR THERAPY (2006)
Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors
L Chapatte et al.
CANCER RESEARCH (2006)
Current state and perspectives of dendritic cell vaccination in cancer immunotherapy
A. Farkas et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2006)
Targeting antigens to dendritic cells in vivo
Paul J. Tacken et al.
IMMUNOBIOLOGY (2006)
Induction of therapeutic antitumor immunity by in vivo administration of a lentiviral vaccine
JH Kim et al.
HUMAN GENE THERAPY (2005)
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody
PJ Tacken et al.
BLOOD (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity
YK He et al.
JOURNAL OF IMMUNOLOGY (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response
MJ Palmowski et al.
JOURNAL OF IMMUNOLOGY (2004)
Adenoviruses as vaccine vectors
N Tatsis et al.
MOLECULAR THERAPY (2004)
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity
DH Barouch et al.
JOURNAL OF IMMUNOLOGY (2004)
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells
WW Overwijk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Current developments in cancer vaccines and cellular immunotherapy
A Ribas et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8+ T cell responses
C Esslinger et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The use of dendritic cells in cancer immunotherapy
G Schuler et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34+ cord blood-derived dendritic cells
A Temme et al.
GENE THERAPY (2002)
Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors
C Lois et al.
SCIENCE (2002)
Lentiviral vector-mediated tyro sinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma
P Metharom et al.
HUMAN GENE THERAPY (2001)
Regulation of T cell immunity by dendritic cells
A Lanzavecchia et al.
CELL (2001)
A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR - Subunit organization and binding to multivalent ligands
DA Mitchell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens
N Okada et al.
BRITISH JOURNAL OF CANCER (2001)
Infection of human dendritic cells by a Sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein
JP Gardner et al.
JOURNAL OF VIROLOGY (2000)
An autologous oral DNA vaccine protects against murine melanoma
R Xiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
TBH Geijtenbeek et al.
CELL (2000)
Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system
R Schroers et al.
MOLECULAR THERAPY (2000)
Share Paper
